Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,277
Award facts
- Contract value 100% obligated
- $21,276.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $21,276.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, was executed without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was made under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense healthcare operations globally.
As a prime vendor under the PPV-G GEN V program, DMS Pharmaceutical Group supplies a broad portfolio of pharmaceutical products and medical consumables to support military healthcare facilities, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The parent IDC, awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. This delivery order represents one of numerous awards issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division, reflecting the company's established performance as a critical supplier within the federal pharmaceutical supply chain since its registration in the System for Award Management in July 2001.
Quick answers
Who was awarded contract SPE2DU26FENWZ?
SPE2DU26FENWZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DU26FENWZ worth?
The government has obligated $21,277 on SPE2DU26FENWZ.
Is contract SPE2DU26FENWZ an order under another contract?
Yes. SPE2DU26FENWZ is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWZ competed?
The extent of competition for SPE2DU26FENWZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award